Author:
Jia Weidong,Zhu Zhiqiang,Zhang Tengyue,Fan Gaofei,Fan Pingsheng,Liu Yabei,Duan Qiaohong
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference17 articles.
1. Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3–12
2. Sangisetty SL, Miner TJ (2012) Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 4:87–95
3. Saada E, Follana P, Peyrade F, Mari V, Francois E (2011) Pathogenesis and management of refractory malignant ascites. Bull Cancer 98:679–687 (in French)
4. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234
5. Geng M, Ma T, YeE ZB, Ji YB, Lou GY, Xi WQ, Jiang JS, Xia HQ, Li H (2006) In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites. Zhonghua Zhong Liu Za Zhi 28:460–463 (in Chinese)
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献